Glucagon-like peptide-1 receptor agonists and gastrointestinal adverse events: a systematic review and meta-analysis
Weight Watchers (WW) offers an established, structure-first approach to weight loss that includes: A points-based food system that simplifies daily eating decisions App-based food, weight, and activity tracking Community accountability through workshops and digital support Access to GLP-1 medications through AccessMed+ Educational resources focused on nutrition, movement, and consistency WW added clinical pathways to complement its existing points system and community model
GLP-1 therapy provides a new avenue for managing PCOS-related fertility issues effectively
One of the most consequential changes in 2026 is the loss of exclusivity for semaglutide, beginning in early 2026 across major markets including India, China, Brazil, Turkey and Canada, with semaglutide having lost exclusivity in India on 20th March 2026
Back Labhart, A (1978) 'Intuition, luck and misfortune in diabetes research', Diabetologia , 14, 353-58
Epub 2021 Feb 10
